Home LiteratureArticle Details
PMID: 15067051 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 172 ·No. 8 ·2004-04-15 ·Pages 4752-61

Vahlenkamp TW, Tompkins MB, Tompkins WA

Abstract

Disease progression of feline immunodeficiency virus (FIV) infection is characterized by up-regulation of B7.1 and B7.2 costimulatory molecules and their ligand CTLA4 on CD4(+) and CD8(+) T cells. The CD4(+)CTLA4(+)B7(+) phenotype described in FIV(+) cats is reminiscent of CD4(+)CD25(+)CTLA4(+) cells, a phenotype described for immunosuppressive T regulatory (Treg) cells. In the present study, we describe the phenotypic and functional characteristics of CD4(+)CD25(+) T cells in PBMC and lymph nodes (LN) of FIV(+) and control cats. Similar to Treg cells, feline CD4(+)CD25(+) but not CD4(+)CD25(-) T cells directly isolated from LN of FIV(+) cats do not produce IL-2 and fail to proliferate in response to mitogen stimulation. Unstimulated CD4(+)CD25(+) T cells from FIV(+) cats significantly suppress the proliferative response and the IL-2 production of Con A-stimulated autologous CD4(+)CD25(-) T cells compared with unstimulated CD4(+)CD25(+) T cells from FIV(-) cats. Flow-cytometric analysis confirmed the apparent activation phenotype of the CD4(+)CD25(+) cells in LN of chronically FIV(+) cats, because these cells showed significant up-regulation of expression of costimulatory molecules B7.1, B7.2, and CTLA4. These FIV-activated, anergic, immunosuppressive CD25(+)CTLA4(+)B7(+)CD4(+) Treg-like cells may contribute to the progressive loss of T cell immune function that is characteristic of FIV infection.

MeSH Terms
Animals Antigens, CD/biosynthesis,metabolism Antigens, Differentiation/biosynthesis Antigens, Viral/biosynthesis B7-1 Antigen/biosynthesis,metabolism B7-2 Antigen CTLA-4 Antigen Cats Cell Division/immunology Cell Separation Cells, Cultured Chronic Disease Coculture Techniques Concanavalin A/pharmacology Feline Acquired Immunodeficiency Syndrome/immunology,virology Immune Tolerance Immunodeficiency Virus, Feline/immunology Immunophenotyping Interleukin-2/biosynthesis,deficiency Ligands Lipopolysaccharides/pharmacology Lymph Nodes/cytology,immunology Lymphocyte Activation/immunology Lymphocyte Count Membrane Glycoproteins/biosynthesis,metabolism Receptors, Interleukin-2/biosynthesis,blood,metabolism T-Lymphocyte Subsets/immunology,metabolism,virology T-Lymphocytes, Regulatory/immunology,metabolism,virology Up-Regulation/immunology
Chemicals
Antigens, CD Antigens, Differentiation Antigens, Viral B7-1 Antigen B7-2 Antigen CTLA-4 Antigen Interleukin-2 Ligands Lipopolysaccharides Membrane Glycoproteins Receptors, Interleukin-2 Concanavalin A
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Vahlenkamp Thomas W
Immunology Program, North Carolina State University, Raleigh, NC 27606, USA.
Tompkins Mary B
Tompkins Wayne A F
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2004-04-15
Pages
4752-61
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI38177 · United States
NIAID NIH HHS · AI43858 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com